mrz 2549 has been researched along with cyclazocine in 1 studies
Studies (mrz 2549) | Trials (mrz 2549) | Recent Studies (post-2010) (mrz 2549) | Studies (cyclazocine) | Trials (cyclazocine) | Recent Studies (post-2010) (cyclazocine) |
---|---|---|---|---|---|
6 | 0 | 0 | 855 | 30 | 7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fitzjarrell, AT; Heath, RG; Walker, CF | 1 |
1 other study(ies) available for mrz 2549 and cyclazocine
Article | Year |
---|---|
Kappa opiate receptor agonists: effects on behavior and on brain function and structure in rhesus monkeys.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Behavior, Animal; Benzomorphans; Brain; Computers; Cyclazocine; Dose-Response Relationship, Drug; Electroencephalography; Ethylketocyclazocine; Evoked Potentials; Macaca mulatta; Naloxone; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa | 1984 |